BSE : BLISSGVS.BO
$13.3 (2.93%)
BSE
Shibroor Narsimha Kamath
Drug Manufacturers - Specialty & Generic
Healthcare
BLISSGVS.BO
1033
IN
INR
0.02
4.02
3.38
0.15
0.04
$9.27B
5.33
4.25
102.24
4.44
$12
$1.29B
13.93%
20.45%
11.26%
8.65%
38.39
0.75
0.75
4/5
0 Analysts
%
12.90
4/9
$7.11B
$14.92B
$2.61B
$2.02B
No key metrics data available.
| Name | Title |
|---|---|
| Deepak Sawant | Chief Financial Officer |
| Aditi H. Bhatt | Compliance Officer, Company Secretary & Nodal Officer |
| Shibroor Narsimha Kamath | MD, CEO & Director |
| Shreekrushna Joshi | Head of Legal |
| Sourya Das | Associate Vice President |
| Prashant Churi | Vice President of Technical Operations |
No votes yet today — be the first to share your view!
About Bliss GVS Pharma Limited (BSE:BLISSGVS.BO) Stock
Bliss GVS Pharma Limited, founded in 1984 and based in Mumbai, India, operates as a pharmaceutical enterprise focused on the development, production, and commercialization of a vast array of medicinal formulations and general healthcare items. Its comprehensive pharmaceutical offerings span numerous dosage forms, such as capsules, tablets, injections, oral suspensions, topical creams/gels/ointments, effervescent tablets, eye/ear drops, transdermal patches, and parenterals. In addition to prescription pharmaceuticals, the company manufactures a wide selection of over-the-counter (OTC) and personal care products, including balms, lotions, shampoos, soaps, nasal inhalers, and various sprays and solutions. Addressing a broad spectrum of medical conditions, Bliss GVS's therapeutic catalogue fea ... tures anti-infectives (e.g., antibacterial, anti-malarial, anti-fungal), anti-inflammatory agents, analgesics, gastrointestinal treatments (such as anti-ulcer and anti-diarrheal medications), anti-diabetics, respiratory support products (like antitussives and nasal decongestants), and an extensive range of nutritional, dermatological, and general wellness supplements, including vitamins, body supplements, and specialized hygiene solutions. The company's products are also distributed internationally through its export operations.
Frequently Asked Questions
What is the current Bliss GVS Pharma Limited (BLISSGVS.BO) stock price?
Bliss GVS Pharma Limited(BSE:BLISSGVS.BO) stock price is $467.4 in the last trading session. During the trading session, BLISSGVS.BO stock reached the peak price of $552.9 while $118.35 was the lowest point it dropped to. The percentage change in BLISSGVS.BO stock occurred in the recent session was 2.93% while the dollar amount for the price change in BLISSGVS.BO stock was $13.3.
BLISSGVS.BO's industry and sector of operation?
The BSE listed BLISSGVS.BO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of BLISSGVS.BO?
Deepak Sawant
| Chief Financial Officer
Aditi H. Bhatt
| Compliance Officer, Company Secretary & Nodal Officer
Shibroor Narsimha Kamath
| MD, CEO & Director
Shreekrushna Joshi
| Head of Legal
Sourya Das
| Associate Vice President
How many employees does BLISSGVS.BO have?
Number of BLISSGVS.BO employees currently stands at 1033. BLISSGVS.BO operates from 102, Hyde Park, Mumbai, MA 400072, IN.
Link for BLISSGVS.BO official website?
Official Website of BLISSGVS.BO is: https://www.blissgvs.com
How do I contact BLISSGVS.BO?
BLISSGVS.BO could be contacted at phone #91 22 4216 0000 and can also be accessed through its website. BLISSGVS.BO operates from 102, Hyde Park, Mumbai, MA 400072, IN.
How many shares of BLISSGVS.BO are traded daily?
The average number of BLISSGVS.BO shares traded daily for last 3 months was 105.22K.
What is the market cap of BLISSGVS.BO currently?
The market value of BLISSGVS.BO currently stands at $49.69B with its latest stock price at $467.4